Stockpolly
Search
LIXT · NASDAQ · Biotechnology

Lixte Biotechnology (LIXT)

Develops LB-100 and proton therapy technology for cancer treatment.

$7.21
At close−0.46 (−6.00%)
Watchlist

Something off on this page? Send us feedback.

Breakdown13F · 13D/G · Form 4

Insiders11 holders · as of Jul 2, 202610.44%1.68M shares
Strategic holders1 holder · as of Jun 9, 20264.81%774.9K shares
Otherremainder84.75%13.65M shares

16.10M company shares as of Sep 3, 2026 · holders as of their latest filing

Two share counts disagree (16.10M in the company's Sep 3, 2026 report, 12.36M elsewhere); stakes use the report.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesEvidence
Strategic EP, LLCStrategic
4.81%774,90213Gfiled Jun 9, 2026 ↗
Geordan Garrett PursgloveInsiderdirector, officer: CEO and Chairman of the Board
4.35%700,000Form 4filed Jul 2, 2026 ↗
Vanguard Capital ManagementInstitution
3.87%622,75613Gfiled Jul 31, 2026 ↗
Gil Schwartzberg1Insiderdirector, 10 percent owner
1.33%214,49913G/Afiled Dec 17, 2020 ↗
John S. KovachInsiderdirector, 10 percent owner, officer: President and CEO
0.97%156,12813D/Afiled Dec 17, 2020 ↗
Glenn Krinsky2Insider10 percent owner
0.92%147,50013Gfiled Apr 7, 2022 ↗
Robert Greenberg3Insider10 percent owner
0.86%138,02613G/Afiled Dec 17, 2020 ↗
Peter StazzoneInsiderofficer: Chief Financial Officer
0.62%100,000Form 4filed Jul 2, 2026 ↗
Jason David SawyerInsiderdirector
0.40%65,000Form 4filed Jul 2, 2026 ↗
Lourdes FelixInsiderdirector
0.34%55,000Form 4filed Jul 2, 2026 ↗
Michael Andrew HollowayInsiderdirector
0.25%40,000Form 4filed Jul 2, 2026 ↗
Guy Warren PrimusInsiderdirector
0.25%40,000Form 4filed Jul 2, 2026 ↗
Stuart D. PorterInsiderdirector
0.16%25,000Form 4filed Jun 1, 2026 ↗
FormanInsider
—0.08% of class, as filed—13G/Afiled Apr 7, 2022 ↗
K. KinraInsider
—8.35% of class, as filed—13Gfiled Apr 13, 2017 ↗
Arthur Riggs4Insider10 percent owner
0.63%101,833Form 4filed Dec 11, 2018 ↗
Rene Bernards5Insiderdirector
0.16%25,000Form 4filed Oct 5, 2023 ↗
Bastiaan Jeroen van der Baan5Insiderdirector, officer: President and CEO
0.07%11,000Form 4filed Oct 5, 2023 ↗
Philip F. Palmedo6Insiderdirector
0.07%10,706Form 4filed Apr 26, 2021 ↗
Stephen J. Forman6Insiderdirector
0.04%5,814Form 4filed Apr 26, 2021 ↗
Yun Yen7Insiderdirector
0.03%5,263Form 4filed Dec 4, 2020 ↗
Regina Brown8Insiderdirector
0.00%630Form 4filed Nov 22, 2022 ↗
Eric Forman9Insiderofficer: Vice President and COO
0.00%0Form 4filed Dec 13, 2022 ↗
Hung Tak Ho10Insider10 percent owner
0.00%0Form 4filed Dec 9, 2020 ↗
  1. Gil Schwartzberg's transaction reports restate only vehicles that traded; the 2020 ownership statement (214.5K) is used instead.
  2. Glenn Krinsky's transaction reports restate only vehicles that traded; the 2022 ownership statement (147.5K) is used instead.
  3. Robert Greenberg's transaction reports restate only vehicles that traded; the 2020 ownership statement (138.0K) is used instead.
  4. Last filed Dec 11, 2018; leaving the company requires no filing. Not in the bar.
  5. Last filed Oct 5, 2023; leaving the company requires no filing. Not in the bar.
  6. Last filed Apr 26, 2021; leaving the company requires no filing. Not in the bar.
  7. Last filed Dec 4, 2020; leaving the company requires no filing. Not in the bar.
  8. Last filed Nov 22, 2022; leaving the company requires no filing. Not in the bar.
  9. Last filed Dec 13, 2022; leaving the company requires no filing. Not in the bar.
  10. Last filed Dec 9, 2020; leaving the company requires no filing. Not in the bar.

13D/13G — an ownership statement filed at 5% or more · Form 4 — an insider's transaction report

Institutions13F

No 13F holders on record.

Ownership statements13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Strategic EP, LLC5.10%774.9K13GJun 9, 2026 ↗
Vanguard Capital Management5.02%622.8K13GJul 31, 2026 ↗

Insider tradesForm 4

Latest trades

No open-market trades in the last 12 months.

CongressHouse and Senate disclosures

Not reported.